Research theme for competitive and other funds (4):
2023 - 2026 Efficacy of Transmaternal Human Cord Blood Cell Transplantation Therapy for Fetal Tissue Damage Caused by Ischemia-Reperfusion
2021 - 2024 Unveil the regulatory functions of cord blood in the therapeutic mechanism of cord blood transfusion against cerebral palsy
2020 - 2021 再生医療への応用を目指した臍帯血細胞が分泌する液性因子のプロファイリング
2016 - 2019 脳性麻痺に対する臍帯血移植治療におけるケモカインネットワークの役割の解明
Papers (22):
Hiroaki Kikuchi, Shiho Saitoh, Terumasa Tsuno, Rina Hosoda, Nobuyasu Baba, Feifei Wang, Naomi Mitsuda, Masayuki Tsuda, Nagamasa Maeda, Yusuke Sagara, et al. Safety and feasibility of autologous cord blood infusion for improving motor function in young children with cerebral palsy in Japan: A single-center study. Brain and Development. 2022. 44. 10. 681-689
Nobuyasu Baba, Feifei Wang, Michiro Iizuka, Yuan Shen, Tatsuyuki Yamashita, Kimiko Takaishi, Emi Tsuru, Sachio Matsushima, Mitsuhiko Miyamura, Mikiya Fujieda, et al. Induction of regional chemokine expression in response to human umbilical cord blood cell infusion in the neonatal mouse ischemia-reperfusion brain injury model. PLoS ONE. 2019. 14. 9. e0221111-e0221111
日本サイトメトリー学会
, JAPAN SOCIETY OF OBSTETRICS AND GYNECOLOGY
, THE JAPANESE SOCIETY FOR REGENERATIVE MEDICINE
, UNBILICAL CORD BLOOD FOR REGENERATIVE MEDICINE
, THE JAPANESE SOCIETY FOR IMMUNOLOGY